| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
179,400,000 |
| Market
Cap: |
209.90(M) |
| Last
Volume: |
2,201,087 |
Avg
Vol: |
2,290,588 |
| 52
Week Range: |
$0.449 - $1.83 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Delivery |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nektar Therapeutics is a research-based biopharmaceutical company. Co.'s research and development pipeline of investigational drugs includes potential therapies for cancer and autoimmune disease. Co.'s proprietary programs include: Immuno-oncology, which involves in developing medicines that target biological pathways which stimulate and sustain the body's immune response in order to fight cancer; and Pain, NKTR-181, a mu-opioid analgesic drug candidate patients with chronic low back pain. Co.'s NKTR-358 is an investigational drug designed to correct the underlying immune system imbalance in the body which occurs in patients with autoimmune disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
105,765 |
142,418 |
224,760 |
560,568 |
| Total Sell Value |
$175,994 |
$200,918 |
$253,717 |
$1,308,011 |
| Total People Sold |
5 |
5 |
7 |
10 |
| Total Sell Transactions |
5 |
8 |
16 |
38 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Robin Howard W |
President & CEO |
• • – |
2014-11-25 |
4 |
OE |
$14.52 |
$6,783,744 |
D/D |
467,200 |
477,200 |
|
- |
|
| Labrucherie Gil M |
SVP & General Counsel |
• – – |
2014-11-24 |
4 |
AS |
$15.04 |
$157,920 |
D/D |
(10,500) |
3,751 |
|
- |
|
| Labrucherie Gil M |
SVP & General Counsel |
• – – |
2014-11-24 |
4 |
OE |
$13.02 |
$136,710 |
D/D |
10,500 |
14,251 |
|
- |
|
| Robin Howard W |
President & CEO |
• • – |
2014-11-24 |
4 |
AS |
$15.02 |
$1,994,656 |
D/D |
(132,800) |
10,000 |
|
- |
|
| Robin Howard W |
President & CEO |
• • – |
2014-11-24 |
4 |
OE |
$14.52 |
$1,928,256 |
D/D |
132,800 |
142,800 |
|
- |
|
| Lingnau Lutz |
Director |
– • – |
2014-11-24 |
4 |
AS |
$15.02 |
$225,300 |
D/D |
(15,000) |
16,450 |
|
- |
|
| Lingnau Lutz |
Director |
– • – |
2014-11-24 |
4 |
OE |
$8.81 |
$132,150 |
D/D |
15,000 |
31,450 |
|
- |
|
| Labrucherie Gil M |
SVP & General Counsel |
• – – |
2014-11-03 |
4 |
AS |
$13.78 |
$136,422 |
D/D |
(9,900) |
3,751 |
|
- |
|
| Labrucherie Gil M |
SVP & General Counsel |
• – – |
2014-11-03 |
4 |
OE |
$11.38 |
$112,662 |
D/D |
9,900 |
13,651 |
|
- |
|
709 Records found
|
|
Page 29 of 29 |
|
|
0.01 (0.86%) 
